Top

Gepubliceerd in:

01-04-2013 | Original Article

Cognitive Behavioral Therapy Versus Progressive Muscle Relaxation Training for Multiple Somatoform Symptoms: Results of a Randomized Controlled Trial

Auteurs: Annette Schröder, Jens Heider, Alexandra Zaby, Richard Göllner

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 2/2013

Abstract

Although unexplained multiple symptoms and somatoform disorders are a highly prevalent condition in primary practice, few randomized controlled trials of cognitive behavioral therapy (CBT) have been conducted. Moreover, most of these trials have used only the usual medical treatment or wait list control groups. The present study included 134 outpatients showing at least two medically unexplained symptoms. They were randomly assigned to eight weekly group sessions of either CBT or progressive muscle relaxation (PMR) or wait list control and were assessed before and after treatment as well as 6 months after the end of treatment. The number and intensity of somatoform symptoms were the primary outcome measures; depression, anxiety and physical and mental health constituted the secondary outcome measures. CBT showed small effects (Cohen’s d = 0.44) for the treatment of somatoform disorders. Benefits of the treatment were sustained over 6 months of follow-up. However, no differential effects of CBT and PMR were found. In conclusion, both CBT and PMR appear to be effective treatments for multiple somatoform symptoms.

vorige artikel The Role of Facial Feedback in the Modulation of Clinically-Relevant Ambiguity Resolution

volgende artikel Is There a Core Process Across Depression and Anxiety?

In this article we use these terms synonymously.

Allen, L. A., Escobar, J. I., Lehrer, P. M., Gara, M. A., & Woolfolk, R. L. (2002). Psychosocial treatments for multiple unexplained physical symptoms: A review of the literature. Psychosomatic Medicine, 64, 939–950.PubMedCrossRef

Allen, L. A., Woolfolk, R. L., Escobar, J. I., Gara, M. A., & Hamer, R. M. (2006). Cognitive-behavioral therapy for somatization disorder: A randomized controlled trial. Archives of Internal Medicine, 166(14), 1512–1518.PubMedCrossRef

Barsky, A. J., & Borus, J. F. (1999). Functional somatic syndromes. Annals of Internal Medicine, 133, 910–921.

Barsky, A. J., Orav, E. J., & Bates, D. W. (2005). Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Archives of General Psychiatry, 62, 903–910.PubMedCrossRef

Bernstein, D. A., & Borkovec, T. D. (1992). In M. Amler, & S. Gröninger (Eds.) Entspannungs-Training. Handbuch der Progressiven Muskelentspannung [Relaxation training. Handbook of progressive muscle relaxation] (Vol. 16). München: Pfeiffer.

Bleichhardt, G., Timmer, B., & Rief, W. (2004). Cognitive-behavioural therapy for patients with multiple somatoform symptoms—A randomised controlled trial in tertiary care. Journal of Psychosomatic Research, 56(4), 449–454.PubMedCrossRef

Bridges, K. W., & Goldberg, D. P. (1985). Somatic presentations of DSM-III psychiatric disorders in primary care. Journal of Psychosomatic Research, 29, 563–569.PubMedCrossRef

Bullinger, M., & Kirchberger, I. (1998). SF-36. Fragebogen zum Gesundheitszustand [SF-36. Health survey questionnaire]. Göttingen: Hogrefe.

Creed, F., & Barsky, A. J. (2004). A systematic review of the epidemiology of somatisation disorder and hypochondriasis. Journal of Psychosomatic Research, 56(4), 391–408.PubMedCrossRef

De Waal, M. W. M., Arnold, I. A., Eekhof, J. A. H., & van Hemert, A. (2004). Somatoform disorders in general practice—Prevalence, functional impairment and comorbidity with anxiety and depressive disorders. British Journal of Psychiatry, 184, 470–476.PubMedCrossRef

Deary, V., Chalder, T., & Sharpe, M. (2007). The cognitive behavioural model of medically unexplained symptoms: A theoretical and empirical review. Clinical Psychology Review, 27(7), 781–797.PubMedCrossRef

Dimsdale, J., & Creed, F. (2009). The proposed diagnosis of somatic symptom disorder in DSM-V to replace somatoform disorders in DSM-IV—A preliminary report. Journal of Psychosomatic Research, 66, 473–476.PubMedCrossRef

Escobar, J. I., Gara, M., Cohen Silver, R., Waitzkin, H., Holman, A., & Compton, W. (1998). Somatization disorder in primary care. British Journal of Psychiatry, 173, 262–266.PubMedCrossRef

Escobar, J. I., Gara, M. A., Diaz-Martinez, A. M., Interian, A., Warman, M., Allen, L., et al. (2007). Effectiveness of a time-limited cognitive behavior therapy-type intervention among primary care patients with medically unexplained symptoms. Annals of Family Medicine, 5(4), 328–335.PubMedCrossRef

Fava, G. A., & Wise, T. N. (2007). Issues for DSM-V: Psychological factors affecting either identified or feared medical conditions: A solution for somatoform disorders. American Journal of Psychiatry, 164, 1002–1003.PubMedCrossRef

Fink, P., & Schröder, A. (2010). One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. Journal of Psychosomatic Research, 68, 415–426.PubMedCrossRef

Gureje, O., & Simon, G. (1999). The natural history of somatization in primary care. Psychological Medicine, 29, 669–676.PubMedCrossRef

Hellman, C., Budd, M., Borysenko, J., McClelland, D., & Benson, H. (1990). A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behavioral Medicine, 16, 165–173.PubMedCrossRef

Henningsen, P., Zipfel, S., & Herzog, W. (2007). Management of functional somatic syndromes. Lancet, 369, 946–955.PubMedCrossRef

Herrmann, C. (1997). International experiences with the Hospital Anxiety and Depression Scale—A review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17–41.PubMedCrossRef

Herrmann, C., & Buss, U. (1994). Vorstellung und Validierung einer deutschen Version der “Hospital Anxiety and Depression Scale” (HAD-Skala) [Presentation and validation of a German version of the “Hospital Anxiety and Depression Scale” (HAD-Scale)]. Diagnostica, 40(2), 143–154.

Hiller, W., & Fichter, M. M. (2004). High utilizers of medical care: A crucial subgroup among somatizing patients. Journal of Psychosomatic Research, 56, 437–443.PubMedCrossRef

Hiller, W., Zaudig, M., & Mombour, W. (1997). Internationale Diagnosen-Checklisten für ICD-10 und DSM-IV [International Diagnostic Checklists for ICD-10 and DSM-IV]. Bern: Huber.

Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65–70.

Jacobson, N., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59(1), 12–19.PubMedCrossRef

Kashner, T., Rost, K., Cohen, B., Anderson, M., & Smith, G. (1995). Enhancing the health of somatization disorder patients. Effectiveness of short-term group therapy. Psychosomatics, 36(5), 462–470.PubMedCrossRef

Kirmayer, L. J., & Robbins, J. M. (1991). Three forms of somatization in primary care. Journal of Nervous and Mental Disease, 179, 647–655.PubMedCrossRef

Kleinstäuber, M., Witthöft, M., & Hiller, W. (2011). Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: A meta-analysis. Clinical Psychology Review, 31(1), 146–160.PubMedCrossRef

Kroenke, K. (2007). Efficacy of treatment for somatoform disorders: A review of randomized controlled trials. Psychosomatic Medicine, 69(9), 881–888.PubMedCrossRef

Kroenke, K., Spitzer, R. L., deGruy, F. V., Hahn, S. R., Linzer, M., Williams, J. B. W., et al. (1997). Multisomatoform disorder: An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Archives of General Psychiatry, 54, 352–358.PubMedCrossRef

Lidbeck, J. (1997). Group therapy for somatization disorders in general practice: Effectiveness of a short cognitive-behavioural treatment model. Acta Psychiatrica Scandinavica, 96(1), 14–24.PubMedCrossRef

Looper, K. J., & Kirmayer, L. J. (2002). Behavioral medicine approaches to somatoform disorders. Journal of Consulting and Clinical Psychology, 70, 810–827.PubMedCrossRef

Martin, A., Rauh, E., Fichter, M. M., & Rief, W. (2007). A one-session treatment for patients suffering from medically unexplained symptoms in primary care: A randomized clinical trial. Psychosomatics, 48, 294–303.PubMedCrossRef

Mayou, R., Kirmayer, L. J., Simon, G., Kroenke, K., & Sharpe, M. (2005). Somatoform disorders: Time for a new approach in DSM-V. American Journal of Psychiatry, 162(5), 847–855.PubMedCrossRef

McLeod, C. C., & Budd, M. A. (1997). Treatment of somatization in primary care: Evaluation of the Personal Health Improvement Program. HMO Practice, 11(2), 88–94.PubMed

Mohr, D. C., Spring, B., Freedland, K. E., Beckner, V., Arean, P., Hollon, S. D., et al. (2009). The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics, 78(5), 275–284.PubMedCrossRef

Nanke, A., & Rief, W. (2003). Zur Inanspruchnahme medizinischer Leistungen bei Patienten mit somatoformen Störungen [Features of health care utilization in patients with somatoform disorders]. Psychotherapeut, 48, 329–335.CrossRef

Nezu, A. M., Nezu, C. M., & Lombardo, E. R. (2001). Cognitive-Behavior Therapy for medically unexplained symptoms: A critical review of the treatment literature. Behavior Therapy, 32, 537–583.CrossRef

Ohm, D. (2003). Stressfrei durch Progressive Muskelentspannung [Progressive muscle relaxation for stress relief]. Stuttgart: Trias.

Riddle, D., Lee, K., & Stratford, P. (2001). Use of SF-36 and SF-12 health status measures: A quantitative comparison for groups versus individual patients. Medical Care, 39(8), 867–878.PubMedCrossRef

Rief, W., Bleichhardt, G., & Timmer, B. (2002). Gruppentherapie für somatoforme Störungen - Behandlungsleitfaden, Akzeptanz und Prozessqualität [Group therapy for somatoform disorders: Treatment guidelines, acceptance, and process quality]. Verhaltenstherapie, 12, 183–191.CrossRef

Rief, W., Henningsen, P., & Hiller, W. (2006). Classification of somatoform disorders. The American Journal of Psychiatry, 163(4), 746–747.PubMedCrossRef

Rief, W., & Hiller, W. (1999). The psychological treatment of somatoform disorders. In Y. Ono, A. Janca, M. Asai, & N. Sartorius (Eds.), Somatoform disorders. A Worldwide perspective (pp. 212–217). Tokyo: Springer.CrossRef

Rief, W., & Hiller, W. (2003). A new approach to the assessment of the treatment effects of somatoform disorders. Psychosomatics, 44(6), 492–498.PubMedCrossRef

Sharpe, M., Peveler, R., & Mayou, R. (1992). The psychological treatment of patients with functional somatic symptoms: A practical guide. Journal of Psychosomatic Research, 36(6), 515–529.PubMedCrossRef

Speckens, A. E. M., van Hemert, A. M., Spinhoven, P., Hawton, K. E., Bolk, J. H., & Rooijmans, H. G. M. (1995). Cognitive behavioural therapy for medically unexplained physical symptoms: A randomised controlled trial. British Medical Journal, 311(7016), 1328–1332.PubMedCrossRef

Stevens, J. P. (2009). Applied multivariate statistics for the social sciences (5th Ed.). New York: Routledge Academic. Retrieved August 10, 2011, from http://www.psypress.com/applied-multivariate-statistics-for-the-social-sciences-fifth-edition-9780805859034.

Sumathipala, A. (2007). What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosomatic Medicine, 69(9), 889–900.PubMedCrossRef

Sumathipala, A., Hewege, S., Hanwella, R., & Mann, A. H. (2000). Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: A feasibility study in Sri Lanka. Psychological Medicine, 30(4), 747–757.PubMedCrossRef

van der Feltz-Cornelis, C. M., & van Balkom, A. (2010). The concept of comorbidity in somatoform disorder—A DSM-V alternative for the DSM-IV classification of somatoform disorders. Journal of Psychosomatic Research, 68, 97–99.PubMedCrossRef

Ware, J., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.PubMedCrossRef

Witthöft, M., & Hiller, W. (2010). Psychological approaches to origins and treatments of somatoform disorders. The Annual Review of Clinical Psychology, 6, 257–283.CrossRef

Titel: Cognitive Behavioral Therapy Versus Progressive Muscle Relaxation Training for Multiple Somatoform Symptoms: Results of a Randomized Controlled Trial
Auteurs: Annette Schröder
Jens Heider
Alexandra Zaby
Richard Göllner
Publicatiedatum: 01-04-2013
Uitgeverij: Springer US
Gepubliceerd in: Cognitive Therapy and Research / Uitgave 2/2013
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-012-9474-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2013

Is There a Core Process Across Depression and Anxiety?

Nighttime Thought Control Strategies and Insomnia Severity

Perfectionistic Thoughts, Personal Standards, and Evaluative Concerns: Further Investigating Relationships to Psychological Distress

Can Paranoid Thoughts be Reduced by Targeting Negative Emotions and Self-Esteem? An Experimental Investigation of a Brief Compassion-Focused Intervention

Cognitive Restructuring and Acceptance: An Empirically Grounded Conceptual Analysis

Changes in Beliefs about the Social Competence of Self and Others Following Group Cognitive-Behavioral Treatment